Skip to contentSkip to filters

We use cookies for analytics.

11 results

Newest first

Expanding mechanisms and therapeutic targets for neurodegenerative disease

Aaron D. Gitler · Department of Genetics, Stanford University

…the depletion of RNA-binding protein TDP-43 from the nucleus of neurons in the brain and spinal cord. A major function of TDP-43 is as a repressor of cryptic exon inclusion during RNA splicing. By re-analyzing RNA-sequencing datasets from human FTD/ALS brains, we discovered dozens of novel cryptic splicing events in important neuronal genes. Single nucleotide polymorphisms in UNC13A are among the strongest hits associated with FTD and ALS in human genome-wi

Thu, Jun 5, 2025 · 14:00 UTC

Seminar · Molecular Neuroscience

Cell-specific regulation of neuronal and glial glucose metabolism by neurodegeneration-associated protein TDP-43

Ismail Gbadamosi, Lesley Motherwell, Izabela Lepiarz-Raba et al. · FENS Forum 2024

…of TAR DNA-binding protein 43 (TDP-43). Notably, unconventional metabolic conditions like type 2 diabetes mellitus and dyslipidemia paradoxically correlate with a better prognosis in ALS and FTLD, hinting at potential metabolic pathways in TDP-43-associated neurodegeneration. To better understand the interplay between TDP-43

ePoster · Neuroscience

Chaperone mediated autophagy is deficient in spinal motoneurons of ALS patients

Daniel Garrigos, Marta Martínez-Morga, Emilio Geijo-Barrientos et al. · FENS Forum 2024

…TDP-43 nuclear clearance and aggregates are identified as a major component of the ubiquitinated neuronal cytoplasmic inclusions deposited in spinal motor neurons both in familiar and sALS patients. Since TDP43 protein contains the HSC70 recognition motif, and, therefore, chaperon mediated autophagy (CMA) function may represent a cellular mechanism to regulate TDP43 cytoplasmic turnover in cells. We

ePoster · Neuroscience

Correlation between motoneuronal survival and VEGF expression in brainstem motoneurons in the SOD1 ALS murine model

Silvia Silva Hucha, M. Estrella Fernández de Sevilla, Kirsty M Humphreys et al. · FENS Forum 2024

ALS is a progressive neurodegenerative disease characterised by the loss of motoneurons (MNs). Some MNs present a lower vulnerability to the disease, including neurons of the oculomotor system (OCM), compared to other cranial MNs (facial or hypoglossal). Vascular endothelial growth factor (VEGF) has shown the ability to protect MNs from degeneration. Overexpression of VEGF is involved in neuroprotection and delayed neurodegeneration of MNs. We have previously described a higher amount of VEGF in the extraocular neurons in control adult rats. The objective of this study in the murine SOD1G93A A

ePoster · Neuroscience

Irreversible shift of TDP-43 into the cytoplasm alters its protein network

Jerneja Nimac, Sonja Prpar Mihevc, Julija Mazej et al. · FENS Forum 2024

TDP-43 is an important DNA/RNA-binding protein that is mainly localized in the cell nucleus. In neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), it is mislocalized and becomes a central component of cytoplasmic protein aggregates. Our aim was to investigate the interactome of wild-type TDP-43 and TDP-43 without nuclear localization signal (dNLS), which mimics a pathological condition in ALS. We generated inducible mammalian cell lines expressing TDP-43wt and TDP-TDP-43dNLS. Using the BioID method, we investigated the interactome of these

ePoster · Neuroscience

RNA-binding properties influence phase separation of TDP-43 in vivo

Cindy Maurel, Natalie Scherer, Grant Richter et al. · FENS Forum 2024

TDP-43 is the hallmark protein of several neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS). This RNA-binding protein can form membrane-less condensates through liquid-liquid phase separation (LLPS). This biophysical process is considered to contribute to the regulation of TDP-43 functions but the precise mechanisms governing TDP-43 LLPS and its implications in homeostasis as well as pathology remain incompletely understood.In this study, we aimed to elucidate the influence of RNA-binding on TDP-43 dynamics and localization in vivo. By applying confocal imaging workflow

ePoster · Neuroscience

Synaptic dysfunction in a hIPSC-derived neuronal model of ALS and FTD

Rachel Jackson, Matthew J Keuss, Peter Harley et al. · FENS Forum 2024

…In many cases the RNA binding protein TDP-43 aggregates in the cytoplasm leading to the loss of its nuclear functions, including as a splicing repressor. This results in the erroneous inclusion of intronic sequences known as cryptic exons (CEs) in several mature mRNAs. Recently, it has been shown that TDP-43 depletion leads to CE inclusion in UNC13A, which encodes a protein crucial for priming synaptic vesicles for release. The UNC13A

ePoster · Neuroscience

…an essential RNA/DNA binding protein, TDP-43. TDP-43 is a key constituent of neuronal ribonucleoprotein (RNP) granules involved in post-transcriptional mRNA regulation, including splicing, mRNA localization and translation of transcripts important for synaptic and axonal maintenance. We and others have previously shown that ALS-linked TDP-43 mutations in the LCD impair axonal transport of RNP granules. Specifically, we found that mutations in the conserved helical segment and flanking r

ePoster · Neuroscience

Programmed Axon Death and its Roles in Human Disease

Michael Coleman · University of Cambridge

Axons degenerate before the neuronal soma in many neurodegenerative diseases. Programmed axon death (Wallerian degeneration) is a widely-occurring mechanism of axon loss that is well understood and preventable in animals. Its aberrant activation by mutation of the pro-survival gene Nmnat2 directly causes axonopathy in mice with severity ranging from mild polyneuropathy to perinatal lethality. Rare biallelic mutations in the homologous human gene cause related phenotypes in patients. NMNAT2 is a negative regulator of the prodegenerative NADase SARM1. Constitutive activation of SARM1 is cytotoxi

Tue, Oct 20, 2020 · 10:00 UTC

Seminar · Neuroscience